MONTREAL, May 15, 2024 (GLOBE NEWSWIRE) -- As part of its mission to support health care across Quebec, The Doggone Foundation has pledged a gift of $150K to the McGill University Health Centre (MUHC) Foundation to support the MUHC's cancer researchers as they advance precision breast cancer care.  From their generous contribution to the construction of the Glen site to their championing of the McGill Interdisciplinary Initiative in Infection and Immunity (Mi4) and lifesaving innovations in cardiovascular research, the Doggone Foundation continuously demonstrates its commitment to advancing health care. "We are on the precipice of major, life-changing breakthroughs in breast cancer research, and the Doggone Foundation is happy to champion the research taking place at the MUHC. Our gift is funding some of the greatest minds in medicine, and that translates to better care and innovation right here in Quebec. At the end of the day, we want to see our community thrive." —Paul Marchand, President of the Doggone Foundation The Doggone Foundation's gift is supporting the work of Dr. Sarkis Meterissian, Director of the MUHC Breast Clinic, Dr. Julia Burnier, Scientist in the Cancer Research Program of the RI-MUHC, and Dr. Morag Park. They are working on finding a breast cancer signature through liquid biopsy, an innovative cancer screening test that detects tumour DNA circulating in the body using a sample of blood. This non-invasive test is the first of its kind and will make it so that breast cancer is always detected early enough to treat. "Supporting the work ...